Author:
Ge Jiahao,Zhang Kangjun,Hu Weijian,Zhou Haihua,Wu Xiaokang
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Rumgay H, Ferlay J, Martel C, Georges D, Ibrahim AS, Zheng R, Wei W, Lemmens VEPP, Soerjomataram I (2022) Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer 161:108–118
2. Zheng Y, Wang S, Cai J, Ke A, Fan J (2021) The progress of immune checkpoint therapy in primary liver cancer. Biochim Biophys Acta 1876:188638
3. Pham L, Kyritsi K, Zhou T, Ceci L, Baiocchi L, Kennedy L, Chakraborty S, Glaser S, Francis H, Alpini G, Sato K (2022) The functional roles of Immune cells in primary Liver Cancer. Am J Pathol 192:826–836
4. Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W (2022) Tumor-associated macrophages in liver cancer: from mechanisms to therapy. Cancer Commun 42:1112–1140
5. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77:1598–1606